Neumora Therapeutics
well tolerated with lower incidence rate compared to placebo | Neumora Therapeutics
Company
Deck Type
IPO
Sector
Industry
Deck date
September 2023
Slide
12 of 32
Related slides by other companies
Genprex
Investor Presentation
November 2024
lung cancer by the numbers | Genprex
Rent The Runway
Results
September 2023
higher inventory availability is associated with lower customer churn data shows that as in stock rate increases customer churn rates decrease depth strategy is expected to result in a improvement in in stock rates in and drive lower churn | Rent The Runway
Aeglea BioTherapeutics
Investor Presentation
February 2022
safety profile results from peace | Aeglea BioTherapeutics
BlackRock
Investor Conference
December 2018
changing client needs align with higher industry projected growth rates | BlackRock
Search Thousands of Presentations by World Leading Companies
Trending:
Addressable Market
Ecosystem
Beauty Market
WACC
NFT
Management Team
Investment Highlights